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Histamine is a biologically active amine abundant in many tissues 
of both animals and man. It has been suggested that histamine plays an 
essential role in many physiologic processes and responses such as gastric 
secretion, tissue growth and repair (1, 2) and reaction to tissue damage. 
Furthermore, histamine has been implicated in several pathological con¬ 
ditions such as peptic ulcer, asthma, allergies, anaphylactic shock, 
histamine headache, and. urticarial reactions (3, 4). Finally, it has 
been suggested, that histamine, may function as a neurotransmittor (5, 6)j 
this possibility will be discussed in some detail below. 
Despite the many suggested physiologic and pathologic roles of 
histamine, the factors controlling its synthesis are not completely 
understood. The mechanism of histamine synthesis by decarboxylation of 
histidine is well known. Histidine decarboxylase, with pyridoxal phos¬ 
phate as cofactor, is generally considered responsible for synthesising 
the majority of tissue histamine. Most workers agree that there are at 
least two types of histidine decarboxylases. 'Evidence for the existence 
of specific histidine decarboxylase, the prototype of which is prepared 
from rat fetuses, and non-specific aromatic L - amino acid decarboxylase, 
the prototype of which may be extracted from guinea pig kidney, has been 
discussed at length by several authors (7,8,9, 10), There may be, how¬ 
ever, more than two enzymes capable of decarboxylating histidine, although 
all known mammaliam histidine decarboxylases are. similar to these two (7). 
A complete discussion of this aspect of histamine synthesis is not within 
the scope of this paper. In the rat histamine synthesis is primarily 
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catalyzed by the specific enzyme (7, 8)* 
Apparently there are. at least three pools of histamine in the 
body, and there may be several. Examples are the histamine in mast 
cells which has a half life of approximately 50 days (11), the rapidly 
turning-over pool of histamine in the gastric and intestinal mucosa with 
a half life of less than 3 hours (12), and. a slowly turning-over tissue 
pool of histamine not in mast cells (12), 
Important as it is, the knowledge of the mechanism of histamine 
synthesis and physiological pools in which histamine exists does not 
unveil the factors which, are directly responsible for the rate of hista¬ 
mine synthesis and thus the quantity of histamine available at any given 
time for biological activity. In 1959 Schayer (13) reported that when 
histamine was released from rats by compound. 48/80, there followed 
shortly thereafter an increased histamine forming capacity (EFC) in the 
skin. The term HFC was used to imply either the production of more 
histidine decarboxylase or simply the greater activity of histidine 
decarboxylase, Since histamine release by 48/80 correlated well with 
degranulation of mast cells, Schayer postulated that the increased HFC 
was due either to increased mast cell mitosis (production of more histi¬ 
dine decarboxylase) or release of inhibition of histidine decarboxylase 
(greater histidine decarboxylase activity), Schayer suggested that this 
inhibition of histidine decarboxylase, if it occured, might be due to a 
part of the granule containing the histamine, or something contained 
in the granule such as serotonin or histamine itself. In 1964 Kahlson 
reported increased HFC in gastric mucosa, following histamine depletion 
with gastrin pretreatment (14), Since gastric mucosa contains no mast 
cells, Kahlson went a step further than Schayer and suggested that it 
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was indeed histamine that inhibited its own synthesis. Since then 
Kahlson has continued to promote the concept of a negative feedback 
control over histamine synthesis based primarily on much furtner evidence 
that whenever histamine is released from a tissue, KFu increases. He 
has recently re.norted this phenomenon to occur during the natural release 
of histamine in anaphylactic shock (15), 
Although the negative feedback theory for the control, of histamine 
synthesis seems attractive as an explanation of the increased HFC in a 
tissue following histamine release, definite proof for or against the 
theory was lacking until Levine (16) showed that high concentrations of 
histamine do not inhibit histidine decarboxylase in, vitro,. Tills evidence 
does not completely rule out the possibility that histamine inhibits 
tissue HFC, but it makes the simple explanation of such an inhibition 
working directly through the synthesizing enzyme quite unlikely. 
Evidence has been reported that naturally-occurring inhibitors of 
histidine decarboxylase activity may exist in gastric tissue of the 
rat (14). The precise, nature of these inhibitors is not known. When 
histamine is released, from tissue., other amines also may be released (17), 
and Levine (10) suggested that perhaps another amine was responsible for 
histidine decarboxylase inhibition. Such a relationship seemed quite 
reasonable in that many of the physiologic responses to amines such as 
serotonin, epinephrine, and norepinephrine (WE) are antagonistic to 
those of histamine (3, 18). Levine studied this possibility in vitro 
(10) and found that the naturally occuring amines, HE and dihydroxyphenyl 
ethylamine (dopamine), and the amino acid dihydroxyphenylalanine (dopa) 
effectively inhibited histidine decarboxylase in concentrations of 
5 x 10 -3m. At this concentration serotonin inhibited histidine decar- 
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boxylase only 19%* while epinephrine , £tist^ine, Lyr amine, ^rtcl ■ 7 ssine 
had less than a 5% inhibitory effect. ME, dopamine, and dopa, on the 
other hand, caused 100% inhibition, which was felt to be reversible 
with, the "characteristics of competition with the cofactor, pyridoical- 
phosphate, and also with substrate," 
ME is the neurotransmitter for most post-ganglionic synapses of the 
sympathetic nervous system and thus plays an essential role in many 
physiologic processes. With the finding that ME inhibits specific histi¬ 
dine decarboxylase in vitro, it becomes of great interest whether ME 
inhibits histamine synthesis in vivo and what effect such an inhibition 
would have on normal physiology. 
Code (16) has recently reviewed the evidence and concluded that 
histamine is very likely a chemical mediator of gastric secretion during 
vagal stimulation. Levine (19) has corroborated this by showing that 
histamine is essential for gastric secretion. It has also been stronger 
suggested that histamine mediates active reflex vasodilitation (5), 
These studies allow for speculation on the possibility that histamine 
may function as a neurotransmitter for portions of the parasympathetic 
system. 
The sympathetic nervous system is generally antagonistic to functions 
of the parasympathetic system, and it seems not unreasonable that this 
antagonism might be mediated through inhibition of synthesis of a para¬ 
sympathetic neurotransm.itter by ME, the sympathetic neurotransmitter. 
If the assumption is made that histamine functions as a neuro¬ 
transmitter for portions of the parasympathetic system, the missing link 
in this sympathetic-parasympathetic antagonism theory becomes the basis 
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for this paper, i.e., docs HE functionally inhibit histamine synthesis 
in vivo.* 
An attempt was made to raise and lower tissue levels of HE in 
heart and stomach by pharmacologic means. If HE does indeed inhibit 
histamine synthesis in vivo, then one would expect to see an inverse 
relationship between tissue levels of NE and tissue and urine levels of 
histamine. However, changes in tissue histamine accompanied by opposite 
changes in urinary histamine would suggest that HE affects release of 
histamine rather than synthesis of histamine. For example, if increased 
tissue HE inhibited histidine decarboxylase, both tissue and urinary 
histamine would decrease. However, if increased tissue HE caused release 
of histamine, tissue histamine would decrease while urinary histamine 
would increase. Tissue and urinary histamine did not change as pre¬ 
dicted in response to changes in HE, On the basis of in vitro studies 
(10) showing dopa to be an effective inhibitor of histidine decarboxy¬ 
lase, dona was given to rats in an'attempt to inhibit histamine synthesis 
in vivo. Administration of dopa likewise failed to alter urinary 
histamine. 
MATERIALS AND METHODS 
Female Sprague-Dawley rats weighing between 135 and 155 grams were 
used in all experiments. In order to raise HE levels In heart and 
stomach, single intraperltoneal injections of pargyline hydrochloride 
^Admittedly, answering this question would not definitively rule 
in or rule out the antagonism theory since HE would not only have to 
physiologically inhibit histamine synthesis in vivo, but would have to 
do so at the nerve endings of tissues exhibiting the antagonism pheno¬ 
menon and, furthermore, do so in a length of time compatible with 
observed physiologic changes in these tissues. 
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(MD - 911) dissolved in sterile isotonic saline in a dose of 50 mg of 
base compound per kg body weight were given. All rats received 1, i? 1 
of either pargyline solution or sterile saline (controls), Controls, 
receiving only sterile saline injections, were included in all experi¬ 
ments, Forty-eight hours prior to treatment the rats were sxrLtched from 
normal diets to a. sucrose and saline diet (8% sucrose and C, saline) 
(20), The sucrose and saline diets were given to allow for empty stomachs 
and a narrower range of values for both WE and histamine in gastric 
mucosa. At various time intervals following drug injection, all rats, 
including controls, were sacrificed bxr a blox7 on the head. The glandular 
portion of the stomach and the heart ventricles were quickly removed, 
weighed, and frozen. Tissues from treated and control rats were assayed 
simultaneously for NS, 
The same procedure was repeated using alpha-methyl tyrosine (@-MT) 
to lower tissue NS (27), The only differences in the procedure from 
that described above for pargyline were that the dose of <§-MT was sus¬ 
pended in the 1,5 ml of saline with 0,07 ml of a 20% solution of 
Tween-80, It was necessary to administer @-MT in this suspension since 
solution cannot be effected at pH greater than 1,5 or less than 9,0, 
It was felt that solutions of these pH extremes might alter tissue BE 
levels and/or histamine levels by stress or direct irritation. 
Using the graphs plotting tissue levels of HE against time follow¬ 
ing drug injection (figs, 1, 2), the injections of pargyline and 
were repeated, this time measuring levels of tissue histamine. 
Then pargyline and @-MT were again administered and the rats were 
placed in metabolic cages and fed only water. Three hours after drug 
injection a 24 hour urine collection was begun. Each urine sample was 
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collected in a glass beaker with 0,5 ml of 3N HCl added, to stabilize 
the. urinary histamine. 
Next urinary histamine was measured under conditions just described 
except that the rats were fed normal diets. 
Finally dopa. was given intraperitoneally in 3 doses of 120 mg/kg 
8 hours apart, A 24 hour urine collection was begun one hour after the 
first injection, and urinary histamine was measured. 
ASSAYS 
All assays were of a fluorometric type. An Atninco-Bowman spectre- 
photofluorometer was employed to measure fluorescence. Tissue HE was 
assayed by the method of Grout, et al, (21) using iodine as the oxidis¬ 
ing agent in the final nrocess for effecting fluorescence. Tissue 
histamine was measured by the method of Shore, et al, (22) with the 
substitution, of H3PO4 for HCL to terminate formation of the fluorescing 
compound (23), Urinary histamine was assayed by the method of Oates, 
et a1, (9) with the same modification described for the tissue histamine 
assay, 
RESULTS 
Tissue levels of NE were successfully increased and decreased, as 
shown in figs, 1 and 2, The pargyline dose of 50 mg base per kg body 
weight was chosen on the basis of previous work (24) showing this to be 
the optimal dose for raising concentrations of tissue NE, This finding 
was confirmed in preliminary studies. Higher doses of pargyline result 
in less than peak elevations in HE, due perhaps to a release pheno¬ 
menon (24), The suspension of @-MT in Tween-80 was apparently well 
absorbed since tissue levels of HE were significantly decreased and none 
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of the suspension was seen in the peritoneal cavity 8 hours after injec¬ 
tion. Desuite the alterations in tissue NE, no changes in tissue hista¬ 
mine were found (Table 1). Also, urinary histamine remained unchanged 
after administration of @-MT (Table 2), However, after treating with 
pargyline, urinary histamine content increased (Table 2). Those rats 
which were fed a normal diet excreted the same amounts of histamine as 
the rats fed a sucrose and saline diet although the variation among rats 
was greater, Intraperitoneal dopa had no effect on urinary histamine 
(Table 3), 
DISCUSSION 
If these in vivo findings had correlated with Levine’s (10) in 
vitro findings, an inverse relationship should have been obtained between 
tissue levels of HE and histamine. That is, high concentrations of HE 
should have inhibited histidine decarboxylase, resulting in a low hista¬ 
mine content and vice versa. In view of the in vitro studies just referred 
to, I shall assume that under proper conditions HE can inhibit histidine 
decarboxylase. Thus it would seem that there are two major possible 
explanations for the results of this study. First, histamine synthesis 
was indeed affected, but, for various reasons which will be discussed, 
the effects were not detected by the methods utilized. Second, histamine 
synthesis was not affected in these experiments. 
First Explanation: Histamine synthesis was affected, 
Perhans tissue content of HE was not changed enough. The pool of 
HE most likely to affect histamine synthesis if a relationship exists 
between the sympathetic and parasympathetic system is that pool at the 
adrenergic nerve endings. This pool represents a small fraction of the 
total HE measured in these experiments. Thus the gross changes in tissue 
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HE brought about in these studies may not reflect a significant change 
in the ME at nerve endings. Perhaps during maximal sympathetic system 
stimulation NS levels at nerve endings transiently rise far outside the 
usual range. 
Tissue histamine concentration also remained unchanged when HE 
levels were decreased. This would seem to indicate that under relatively 
normal physiologic conditions PIE does not inhibit histidine decarboxylase 
or histamine levels would have been increased when HE was decreased. 
From this we may conclude that if NE were the sole inhibiting factor 
in histamine synthesis, histamine would be manufactured at maximal rates 
when the usual concentrations of tissue NE prevail. This seems very 
unlikely in view of Kahlson’s work (14, 15) showing that histamine form¬ 
ing capacity goes up markedly following various stimuli. Again, however, 
we have the problem, df whether or not ME levels were decreased sufficient¬ 
ly, I know of no way to resolve this question other than to refer to the 
HE levels of the untreated animals which were consistently above those 
of the treated animals. 
One might postulate that, as histamine synthesis was blocked, 
histamine catabolism and release mechanisms adapted to the new situation, 
causing the net amount of histamine in a tissue to remain constant. 
However, any change in tissue histamine release or catabolism rates 
should have been evident in urinary excretion of histamine. In fact, 
no change in urinary excretion of histamine occurred when tissue HE was 
decreased, and urinary histamine increased rather than decreased when 
tissue ME was elevated. 
Unfortunately, however, urinary histamine measurements do not 
entirely reflect the amount of histamine produced bjr the animal1 s tissues 
:• ;• SosX'isz >n ys;r? vsityjiis. saariS ni Suoniz SdguoicI WJL 
i 
. iio *i$S at- xt yllr&Xar.B'xi agjnibji© ovtr on Sr, alavaf SI no i So I incise 
' 
loow airPT „ baeaaTro3j& nr - 8.f-val 
visa id lid t r*i Son aso! 3ft anoiSibnoo .rVtCifoieydr Isnnoit 
r: o .(yjr: MJ fi alow adl slaw 3.H Si Ssrfl ebtrlarroo yfi® ©w aids' seal 
, 
t 
. yew on So word I avl 
, :&;■ .’ 75 : '7 ©J j 
, 
-:•« sne in-ed oam ©8aala“ 
Sm/O/i 
« 
ni .id So no.tla'sa*© Tizatur nti Srrsbiv© naad ©v 
t f:s77tr3ao an .tec18id So fyollaiixa ysBr/rct/ fl- 3S,;f® 
• 
. '9 ’ - 
, s^tod , ylsSsm/S'ior'rU 
10 
since over half of the histamine excreted in rat urine is produced in 
the gut by bacteria which dec a rb oxy1a te ingested histidine (25). On the 
other hand, averages of twenty-four hour urinary histamine measurements 
of groups of rats remained quite constant from day to day, which tends 
to make more attractive the idea that urinary histamine should reflect 
any changes in tissue release of histamine. Female Sprague-Dawley rats 
were chosen for these experiments because they excrete a significant por¬ 
tion of their histamine unchanged (25). This greatly facilitated measure¬ 
ment since assays of histamine metabolites are quite tedious. If urinary 
histamine excretion does reflect accurately that histamine released from 
tissues and thus indirect Ip,' that histamine manufactured by the animal, 
the twenty-four hour urinary measurement would be likely to detect changes 
in histamine production too small, to be detected by measuring histamine 
in a single tissue. Urinary histamine excretion did not change after 
treatment with @-MT, and, thus, I must conclude, that when HE levels were 
reduced, histamine synthesis was not affected. 
When pargyline was administered, urinary histamine excretion in¬ 
creased, Since pargyline raises tissue HE levels, histamine concen¬ 
tration in tissues and urine were expected to decline rather than in¬ 
crease if HE inhibited histidine decarboxylase in vivo as it has been 
shown to do in vitro. Histamine levels in the tissues did not change 
after pargyline. treatment, and, thus, the increase of urinary histamine 
must be explained by a mechanism other than the effects of HE or pargy¬ 
line on production or release of histamine from tissues, Pargyline was 
selected for the experiments over other monoamine oxidase inhibitors 
because it reportedly does not inhibit diamine oxidase and thus should 
not interfere with histamine metabolism. If, however, pargyline does 
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inhibit diamine oxidase as do the various hydrazine monoamine oxidase 
inhibitors, the formation of imidazole acetic acid and its riboside 
would have been blocked in these experiments. With this metabolic path¬ 
way blocked presumably more histamine would be excreted in the unaltered 
form rather than as a metabolite. Since only free urinary histamine was 
measured in this study, blocking diamine oxidase would have resulted in 
a falsely elevated reflection of total urinary histamine excretion. 
Further studies should be done to determine if pargyline does indeed 
inhibit diamine oxidase. 
Histamine is metabolized by two major pathways (3), One pathway 
involves methylation of histamine and then oxidation by monoamine oxi¬ 
dase, The other pathway utilizes diamine oxidase and is not dependent 
upon monoamine oxidase, Parpyline would be expected to block the path¬ 
way dependent unon monoamine oxidase, but presumably the only result 
would be a shunting of more histamine to the pathway not utilizing mono¬ 
amine oxidase. It is possible, however, that blocking only one major 
metabolic pathway could lead to the excretion of more histamine in the 
free form. This again would lead to misinterpretation of the total 
excreted histamine as measured in these experiments. 
Second Explanation: Histamine synthesis was unaffected in these 
Experiments. 
It is rather widely accented that the NE which serves as neuro¬ 
transmitter for the sympathetic system is confined to granules near the 
nerve ending until an impulse reaching the nerve ending releases the 
HE from the granules (26), What is not known is what portion of the 
total HE measured in a piece of tissue such as heart or stomach is con¬ 
fined to granules. If in the sympathetically unstimulated tissue the 
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majority of KB resides in granules, then it seems likely that administer¬ 
ing a drug such as pargyline would serve to increase, the number of .Mi 
containing granules or further saturate existing granules. In either 
case the increased amounts of HE would be unavailable to any histidine 
decarboxylase which, as far as is known, exists only in the soluble 
fraction of the cell. The same, of course, would be true tor decreased 
amounts of ITS caused by inhibition of NS synthesis by In the usual 
physiologic situation, however, sympathetic stimulation causes release 
of NS from the. storage granules. It seems reasonable that HE released 
from the granules would be more likely to come into contact with tissue 
histidine decarboxylase than NS confined to the granules, no matter what 
its concentration. If histamine is a neurotransmitter for certain para- 
sympathetic nerves and if NE does inhibit histamine synthesis in vivo, 
it would seem, plausible for such inhibition to occur following sympathetic 
stimulation and granule release of NE. More plausible in that, as pre¬ 
viously mentioned, many effects of sympathetic stimulation are opposite 
to those of parasympathetic stimulation. For example, sympathetic stimula¬ 
tion causing release of NE in stomach wall would result in decreased 
histamine production and lowered gastric acid. A change in the total 
amount of NE in the stomach without release from storage granules would 
not affect histamine synthesis. Such an hypothesis should certainly 
be tested experimentally. One nossibilitT/ would involve isolation of an 
organ such as a heart or stomach with an intact sympathetic nerve attached. 
The tissue would be placed in a nutritive physiologic environment to 
maintain viability. Radioactive histidine placed in this environment 
would be taken up by the tissue and decarboxylated to form, radioactive 
histamine which could be measured. Stimulation of the attached sympa- 
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thetic nerve would release MS to inhibit distidine decarboxylase* Con¬ 
trols without stimulation of the nerve would, of course, be included* 
By using labeled histidine true synthesis could be measured rather than 
just changes in total histamine content which might be altered by hista¬ 
mine release or block of release. A system such as this would be rather 
tedious to set up, but should provide more definitive answers* 
An easier but far less exact experiment might be performed using 
an intact animal and causing sympathetic stimulation followed by measure¬ 
ment of tissue and urinary histamine. Disadvantages of such an experi¬ 
ment would include variable sympathetic stimulation from animal to 
animal and unknown effects of stress on histamine metabolism and release* 
Finally, a word must be said about the administration of dopa. Dopa 
is metabolized in vivo to dopamine and norepinephrine (18), In vitro 
dopa and its metabolites dopamine and norepinephrine were all found to 
be good inhibitors of histidine, decarboxylase (10), By giving dopa 
intraperitoneal1y, one would have expected to have loaded the rats with 
notent histidine, decarboxylase inhibitors, This method would seem to 
circumvent many of the possibilities discussed above in explaining why 
altering tissue levels of MS pharmacologically did not affect histamine 
synthesis, Dopa and dopamine exist normally in the soluble fraction of 
the cell (18) and would be available to affect histidine decarboxylase. 
The fact that the administration of dopa did not result in decreased 
urinary histamine is evidence that either the methods employed in these 
experiments were not suitable for detecting any effect on histidine de¬ 
carboxylase or, for reasons which are not apparent, those compounds 
found to inhibit histidine decarboxylase in vitro do not operate as in¬ 
hibitors in vivo 
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